DM Intelligence (智睿医药)

Guangzhou, China

DM Intelligence is a pharmaceutical technology company focused on artificial intelligence researches, innovations and applications, we strive for breakthroughs in the future of drug discovery and medical imaging diagnosis. AI technology is currently one of the most promising research areas in the field of healthcare. The greatest challenge today in pre-clinical pharmaceutical R&D is identifying a drug candidate that is both effective and safe. However, this is something computers are great at. Aim to find solutions for locating target protein, screening small molecule, predicting chemical compound properties, simulating drug synthesis route and stipulating clinical protocol smarter and faster, we are committed to integrating artificial intelligence technologies into the medical field, working with clinician and pharmaceutical company to provide better service to patients. DM Intelligence is dedicated to contributing to a healthier society worldwide.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out DM Intelligence (智睿医药) on @MedStartr Today #MedMo #MedStartrVentures

https://www.medstartr.ai/s/mh1JqIpGnUg

Get Involved in DM Intelligence (智睿医药)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2018
Website: www.dm-intelligencepharm.com/

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of DM Intelligence (智睿医药)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.

Get Involved in DM Intelligence (智睿医药)